Global Castration Resistant Prostate Cancer Treatment Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Hormonal Therapy
1.2.3 Adding An Anti-Androgen
1.2.4 Stopping An Anti-Androgen
1.2.5 Estrogens
1.2.6 Chemotherapy
1.2.7 Radiation Therapy
1.2.8 Others
1.3 Market by Application
1.3.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Castration Resistant Prostate Cancer Treatment Market Perspective (2018-2029)
2.2 Global Castration Resistant Prostate Cancer Treatment Growth Trends by Region
2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Castration Resistant Prostate Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2024-2029)
2.3 Castration Resistant Prostate Cancer Treatment Market Dynamics
2.3.1 Castration Resistant Prostate Cancer Treatment Industry Trends
2.3.2 Castration Resistant Prostate Cancer Treatment Market Drivers
2.3.3 Castration Resistant Prostate Cancer Treatment Market Challenges
2.3.4 Castration Resistant Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Castration Resistant Prostate Cancer Treatment by Players
3.1.1 Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2018-2023)
3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Castration Resistant Prostate Cancer Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Castration Resistant Prostate Cancer Treatment Revenue in 2022
3.5 Global Key Players of Castration Resistant Prostate Cancer Treatment Head office and Area Served
3.6 Global Key Players of Castration Resistant Prostate Cancer Treatment, Product and Application
3.7 Global Key Players of Castration Resistant Prostate Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Castration Resistant Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2024-2029)
5 Castration Resistant Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Castration Resistant Prostate Cancer Treatment Market Size (2018-2029)
6.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type
6.2.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023)
6.2.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029)
6.2.3 North America Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application
6.3.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023)
6.3.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029)
6.3.3 North America Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
6.4 North America Castration Resistant Prostate Cancer Treatment Market Size by Country
6.4.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023)
6.4.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2018-2029)
7.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023)
7.2.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029)
7.2.3 Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023)
7.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029)
7.3.3 Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
7.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023)
7.4.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Castration Resistant Prostate Cancer Treatment Market Size (2018-2029)
8.2 China Castration Resistant Prostate Cancer Treatment Market Size by Type
8.2.1 China Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023)
8.2.2 China Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029)
8.2.3 China Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
8.3 China Castration Resistant Prostate Cancer Treatment Market Size by Application
8.3.1 China Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023)
8.3.2 China Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029)
8.3.3 China Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Castration Resistant Prostate Cancer Treatment Market Size (2018-2029)
9.2 Asia Castration Resistant Prostate Cancer Treatment Market Size by Type
9.2.1 Asia Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023)
9.2.2 Asia Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029)
9.2.3 Asia Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
9.3 Asia Castration Resistant Prostate Cancer Treatment Market Size by Application
9.3.1 Asia Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023)
9.3.2 Asia Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029)
9.3.3 Asia Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
9.4 Asia Castration Resistant Prostate Cancer Treatment Market Size by Region
9.4.1 Asia Castration Resistant Prostate Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Castration Resistant Prostate Cancer Treatment Market Size by Region (2018-2023)
9.4.3 Asia Castration Resistant Prostate Cancer Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Active Biotech
11.1.1 Active Biotech Company Details
11.1.2 Active Biotech Business Overview
11.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction
11.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.1.5 Active Biotech Recent Developments
11.2 Diagnocure
11.2.1 Diagnocure Company Details
11.2.2 Diagnocure Business Overview
11.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction
11.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.2.5 Diagnocure Recent Developments
11.3 Glaxosmithkline
11.3.1 Glaxosmithkline Company Details
11.3.2 Glaxosmithkline Business Overview
11.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction
11.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.3.5 Glaxosmithkline Recent Developments
11.4 Northwest Biotherapeutics
11.4.1 Northwest Biotherapeutics Company Details
11.4.2 Northwest Biotherapeutics Business Overview
11.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction
11.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.4.5 Northwest Biotherapeutics Recent Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Details
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.5.5 Millennium Pharmaceuticals Recent Developments
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction
11.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.6.5 Hologic Recent Developments
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Details
11.7.2 Spectrum Pharmaceuticals Business Overview
11.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.7.5 Spectrum Pharmaceuticals Recent Developments
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction
11.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.8.5 Abbott Laboratories Recent Developments
11.9 Bayer Healthcare Pharmaceuticals
11.9.1 Bayer Healthcare Pharmaceuticals Company Details
11.9.2 Bayer Healthcare Pharmaceuticals Business Overview
11.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
11.9.5 Bayer Healthcare Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Adding An Anti-Androgen
Table 4. Key Players of Stopping An Anti-Androgen
Table 5. Key Players of Estrogens
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Others
Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2018-2023)
Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2024-2029)
Table 15. Castration Resistant Prostate Cancer Treatment Market Trends
Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers
Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges
Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints
Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Players (2018-2023)
Table 21. Global Top Castration Resistant Prostate Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2022)
Table 22. Global Castration Resistant Prostate Cancer Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Castration Resistant Prostate Cancer Treatment, Headquarters and Area Served
Table 25. Global Key Players of Castration Resistant Prostate Cancer Treatment, Product and Application
Table 26. Global Key Players of Castration Resistant Prostate Cancer Treatment, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2024-2029)
Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Application (2018-2023)
Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Application (2024-2029)
Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Castration Resistant Prostate Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Castration Resistant Prostate Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Castration Resistant Prostate Cancer Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Castration Resistant Prostate Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Castration Resistant Prostate Cancer Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 68. Active Biotech Company Details
Table 69. Active Biotech Business Overview
Table 70. Active Biotech Castration Resistant Prostate Cancer Treatment Product
Table 71. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 72. Active Biotech Recent Developments
Table 73. Diagnocure Company Details
Table 74. Diagnocure Business Overview
Table 75. Diagnocure Castration Resistant Prostate Cancer Treatment Product
Table 76. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 77. Diagnocure Recent Developments
Table 78. Glaxosmithkline Company Details
Table 79. Glaxosmithkline Business Overview
Table 80. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product
Table 81. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 82. Glaxosmithkline Recent Developments
Table 83. Northwest Biotherapeutics Company Details
Table 84. Northwest Biotherapeutics Business Overview
Table 85. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product
Table 86. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 87. Northwest Biotherapeutics Recent Developments
Table 88. Millennium Pharmaceuticals Company Details
Table 89. Millennium Pharmaceuticals Business Overview
Table 90. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 91. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 92. Millennium Pharmaceuticals Recent Developments
Table 93. Hologic Company Details
Table 94. Hologic Business Overview
Table 95. Hologic Castration Resistant Prostate Cancer Treatment Product
Table 96. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 97. Hologic Recent Developments
Table 98. Spectrum Pharmaceuticals Company Details
Table 99. Spectrum Pharmaceuticals Business Overview
Table 100. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 101. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 102. Spectrum Pharmaceuticals Recent Developments
Table 103. Abbott Laboratories Company Details
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product
Table 106. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 107. Abbott Laboratories Recent Developments
Table 108. Bayer Healthcare Pharmaceuticals Company Details
Table 109. Bayer Healthcare Pharmaceuticals Business Overview
Table 110. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 111. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 112. Bayer Healthcare Pharmaceuticals Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2022 VS 2029
Figure 3. Hormonal Therapy Features
Figure 4. Adding An Anti-Androgen Features
Figure 5. Stopping An Anti-Androgen Features
Figure 6. Estrogens Features
Figure 7. Chemotherapy Features
Figure 8. Radiation Therapy Features
Figure 9. Others Features
Figure 10. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2022 VS 2029
Figure 12. Hospital Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Castration Resistant Prostate Cancer Treatment Report Years Considered
Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2022
Figure 19. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2022
Figure 21. North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
Figure 23. North America Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
Figure 24. North America Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 25. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
Figure 29. Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
Figure 30. Europe Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 31. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Castration Resistant Prostate Cancer Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
Figure 39. China Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
Figure 40. Asia Castration Resistant Prostate Cancer Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
Figure 42. Asia Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
Figure 43. Asia Castration Resistant Prostate Cancer Treatment Market Share by Region (2018-2029)
Figure 44. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 54. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 61. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 62. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 63. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 64